ESPERION THERAPEUTICS INC. - COMMON STOCK

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

11 3月 2025 10:17:10 条件 NetDania Notify

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

07 3月 2025 09:47:06 条件 NetDania Notify

Esperion Reports Fourth Quarter and Full Year 2024 Financial Results

04 3月 2025 06:00:00 条件 Nasdaq GlobeNewswire

NetDania - New 12 months Low: ESPERION THERAPEUTICS INC. - COMMON STOCK

03 3月 2025 15:24:27 条件 NetDania Notify

Esperion Partners with CSL Seqirus to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Australia

03 3月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Esperion to Report Fourth Quarter and Full Year 2024 Financial Results on March 4

18 2月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

13 2月 2025 16:30:00 条件 Nasdaq GlobeNewswire

Esperion to Host Virtual Key Opinion Leader Event on Wednesday, January 22, 2025, at 11:30 a.m. ET.

09 1月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Esperion to Participate in Upcoming 43rd Annual J.P. Morgan Healthcare Conference

02 1月 2025 08:00:00 条件 Nasdaq GlobeNewswire

Esperion Strengthens Balance Sheet with Closing of Significant Refinancing Transactions

18 12月 2024 07:00:41 条件 Nasdaq GlobeNewswire

Esperion Announces $210 Million Convertible Debt Financing

13 12月 2024 06:00:00 条件 Nasdaq GlobeNewswire

Esperion Partners with Neopharm to Commercialize NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) in Israel

12 12月 2024 08:00:55 条件 Nasdaq GlobeNewswire

NetDania - New 12 months High: ESPERION THERAPEUTICS INC. - COMMON STOCK

09 12月 2024 14:32:19 条件 NetDania Notify

NetDania - New 12 months High: ESPERION THERAPEUTICS INC. - COMMON STOCK

04 12月 2024 09:47:22 条件 NetDania Notify

NetDania - New 12 months High: ESPERION THERAPEUTICS INC. - COMMON STOCK

02 12月 2024 12:47:28 条件 NetDania Notify

Esperion Announces New Drug Submissions in Canada for NEXLETOL® (bempedoic acid) and NEXLIZET® (bempedoic acid and ezetimibe) Treatments to Reduce LDL-C and Cardiovascular Risk

02 12月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Otsuka Submits New Drug Application in Japan for Bempedoic Acid in the Treatment of Hypercholesterolemia

26 11月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference

21 11月 2024 08:00:00 条件 Nasdaq GlobeNewswire

Esperion Highlights New Exploratory Data from CLEAR Outcomes Trial Highlighting Value of NEXLETOL® (bempedoic acid) in Oral Featured Science Session and Multiple Poster Presentations at AHA Scientific Sessions 2024

18 11月 2024 10:30:00 条件 Nasdaq GlobeNewswire

Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

08 11月 2024 16:15:00 条件 Nasdaq GlobeNewswire